1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Cardiovascular Disease (CVD): new trials by email Literature Review of Cardiovascular Disease (CVD) trials Research Report on Cardiovascular Disease (CVD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities Tadalafil, Ambrisentan, Placebo (Ambrisentan-matching) - Pulmonary Arterial Hypertension (PAH), Comorbidities | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 186 | 2026-04-28 | 2026-05-13 |
Cardiovascular Diseases (1) · Pulmonary Arterial Hypertension (1)
Hypertension, Pulmonary (1) · Lung Diseases (1) · Respiratory Tract Diseases (1)
Tadalafil (1) · ambrisentan (1)
Assistance Publique - Hôpitaux de Paris (1)
France (1)
2023 (1)